Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05436379
NA

Treatment, Emotion, and Neuromodulation of Depression (TREND) Study

Sponsor: Erika Forbes

View on ClinicalTrials.gov

Summary

The investigators will administer theta burst stimulation (TBS) in efforts to observe a decrease in severity of reported depression symptoms. A subset of participants will receive positive affect training during this intervention.

Key Details

Gender

All

Age Range

18 Years - 26 Years

Study Type

INTERVENTIONAL

Enrollment

21

Start Date

2022-06-17

Completion Date

2025-11-30

Last Updated

2026-10-01

Healthy Volunteers

No

Conditions

Interventions

DEVICE

Theta Burst Stimulation

TBS, a next-gen form of transcranial magnetic stimulation (TMS), requires shorter duration and frequency of stimulation and provides comparable clinical efficacy to traditional repetitive TMS for depression. Thus it is an appropriate technique for use with young adults with depression. TBS can be delivered safely and effectively on an accelerated schedule with two sessions/day. Based on an earlier (ongoing) study of TBS to dorsomedial prefrontal cortex, investigators will administer TBS to dmPFC over 2 weeks in young adults with depression. Addressing the behavioral aspects of anhedonia and reward processing, a subset of participants will also receive positive affect training. Magnetic resonance imaging will guide the personalized location of TBS and will be used to examine change in frontostriatal circuitry with TBS. This study has the potential to influence development of new treatments for depression and anhedonia, with possible mechanisms in frontostriatal brain function.

Locations (1)

The University of Pittsburgh, Department of Psychiatry

Pittsburgh, Pennsylvania, United States